

HY-14375 · 10 mM * 1 mL in DMSO
MedChemExpress · Cat: HY-14375
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/CB-300919.htmlDescription
CB 300919 is a quinazoline-based antitumour agent with high activity in the CH1 human ovarian tumour xenograft. CB 300919 has a continuous exposure 96 h growth inhibition IC50 value of 2 nM in human CH1 ovarian tumor xenograft. CB 300919 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition CuAAc with molecules containing Azide groups.